Movement Disorders News

Mar 08, 2018
Non-invasive brain stimulation improves gait impairment of Parkinson disease patients
Transcranial direct current therapy positively impacts mobility and executive functions.
Feb 21, 2018
Simple walking test may help make difficult diagnosis
Findings suggest dual-task tests are inexpensive and effective way to differentiate between idiopathic normal pressure hydrocephalus and progressive supranuclear palsy.
Feb 09, 2018
NIH scientists adapt new brain disease test for Parkinson’s, dementia with Lewy bodies
Early and accurate diagnoses is essential for developing treatments and identifying patients eligible for clinical trials.
Jan 23, 2018
A new therapeutic avenue for Parkinson disease
Clearing senescent astrocytes prevents Parkinson disease in mouse model of sporadic disease.
Jan 12, 2018
Researcher discovers commonalities in brains of people with Huntington disease and Parkinson disease
May lead to a better understanding of the brain's response to neurodegeneration.
Nov 28, 2017
Low frequency brain stimulation improves cognition in Parkinson disease
Rare intraoperative brain recordings identify new brain connection that may be a target for improving cognitive symptoms in Parkinson disease.
Nov 06, 2017
Depressed with a chronic disease? Consider alternative therapies
Scientists find that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease, raising a critical question of whether doctors should enact widespread changes in how they treat millions of depressed Americans.
Sep 13, 2017
Systems analysis points to links between Toxoplasma infection and common brain diseases
Infection with Toxoplasma gondii may alter, and in some cases amplify, several brain disorders, including epilepsy, Alzheimer and Parkinson diseases as well as some cancers.
Aug 31, 2017
FDA Approves AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Tardive Dyskinesia in Adults
AUSTEDO® is the first and only FDA-approved product to treat both tardive dyskinesia in adults and chorea associated with Huntington disease.
Aug 28, 2017
FDA Approves Treatment for Levodopa-Related Dyskinesia in Parkinson Disease
US Food and Drug Administration approves extended-release amantadine capsules (GOCOVRI™) for the treatment of dyskinesia in people with Parkinson disease receiving levodopa-based therapy.
Next ▶